Oral Presentations of Selected Posters of Excellence

Oral Presentations of Selected Posters of Excellence

The Scientific Committee of ICFL 2019 has selected a number of Abstracts of Excellence to be orally presented during the coffee breaks on 28th June in in a designated space in Poster Area Rubin.

You are welcome to join the Scientific Committee who will be chairing these sessions to review and discuss the presentations.

11:00 – 11:30

Rubin Poster Area

 





11:05

 

 

 

 

11:10

 

 

 

 

11:15

 

 

 

 

11:20

 


Oral Presentations of selected Abstracts of Excellence

Chairs:

Arun SanyalVirginia Commonwealth University, USA

Michael Roden, German Center of Diabetology, Germany


FAST SCORE TO IDENTIFY AT-RISK NASH PATIENTS: DEVELOPMENT IN A NAFLD UK COHORT AND EXTERNAL VALIDATION IN 7 INDEPENDENT COHORTS

P. Newsome, J. Boursier, W.K. Chan, M.H. Zheng, S. Czernichow, V.W.S. Wong, A. Nakajima, M. Allison, E. Tsochatzis, Q. Anstee, D. Sheridan, I. Guha, J. Cobbold, A. Paredes, S. Michalak, N.R. Nik Mustapha, Y.Y. Li, V. Paradis, P. Bedossa, S. Harrison (United Kingdom)

EMPAGLIFLOZIN EFFECTIVELYLOWERS HEPATIC STEATOSIS AND IMPROVES HEPATOCELLULAR INTEGRITYIN PATIENTSWITH WELL-CONTROLLED TYPE 2 DIABETES

S. Kahl, S. Gancheva, K. Straßburger, C. Herder, J. Machann, H. Katsuyama, S. Kabisch, E. Henkel, S. Kopf, K. Kantartzis, O. Kuß, Y. Kupriyanova, J.H. Hwang, C. Kasperk, N. Stefan, A. Pfeiffer, A. Birkenfeld, M. Roden (Germany)

CLUSTER ANALYSIS REVEALS THAT PATIENTS WITH SEVERE INSULIN-RESISTANT DIABETES EXHIBIT HIGHER LIVER FAT CONTENT AT DIAGNOSIS AND INCREASED RISK OF LIVER FIBROSIS AT FOLLOW-UP

O.P. Zaharia, K. Strassburger, Y. Kupriyanova, Y. Karusheva, S. Antoniou, K. Bodis, J.H. Hwang, V. Burkart, K. Müssig, O. Asplund, E. Ahlqvist, L. Groop, O. Kuss, J. Szendroedi, M. Roden (Germany)

BODY MASS INDEX (BMI) AND ALCOHOL CONSUME ARE DIRECTLY RELATED WITH LIVER STEATOSIS. RESULTS FROM A PROSPECTIVE MULTICENTER STUDY OF PATIENTS REFERRED FOR HYPERFERRITINEMIA

A. Castiella, E. Zapata, I. Urreta, L. Zubiaurre, P. Otazua, J.M. Alustiza, E. Salvador, J.I. Emparanza (Spain)

15:40 – 16:10Rubin Poster Area

 

 




15:45

 

 

 

15:50

 

 

15:55

 

 

16:00

Oral Presentations of selected Abstracts of Excellence

Chairs:

Rifaat SafadiHadassah Hebrew University, Israel
Quentin AnsteeNewcastle University, UK


MODULATION OF GUT DYSBIOSIS AND INTESTINAL BARRIER FUNCTIONALITY RESTORATION MEDIATE PROTECTIVE EFFECT OF EXERCISE IN AN IN VIVO MODEL OF EARLY OBESITY AND NAFLD

D. Porras, S. Carbajo-Pescador, M. Juárez-Fernández, M.V. García-Mediavilla, S. Martínez-Flórez, M.J. Cuevas, J.L. Mauriz, F. Jorquera, J. González-Gallego, E. Nistal, S. Sánchez-Campos (Spain)

NAMODENOSON ANTI-NAFLD/NASH ACTIVITY IS MEDIATED VIA DE-REGULATION OF THE WNT/β-CATENIN PATHWAY

P. Fishman, S. Cohen, A. Salhab, J. Amer, I. Itzhak, F. Barer, R. Safadi (Israel)

EFFECT OF SAROGLITAZAR IN DIABETIC AND NON-DIABETIC NON-ALCOHOLIC FATTY LIVER PATIENTS ON LIVER STIFFNESS MEASUREMENT: A 6 MONTH FOLLOW UP

S. Dadhich, N. Kumar (India)

AEROBIC EXERCISE TRAINING IMPROVES MITOCHONDRIAL BIOGENESIS AND OXIDATIVE STATUS IN OBESE MICE WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)

M. Santos de Sousa Fernandes, L. Lucena de Simões e Silva, M. Saldanha Kubrusly, T. Ricarlly Lopes de Arruda Lima, C. Rodrigues Muller, B. Cogliati, J.T. Stefano, M. Pinheiro Fernandes, C. Jacques Lagranha, F. Sant'Anna Evangelista, C. P Oliviera (Brazil)

 


Keep Me Updated


​​​ ​​​​​ ​​​​​ ​​​​​